Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.

Abstract

These results demonstrate that sequential determination of chimerism allows the prediction of relapse and death after SCT for acute leukemia. The interval between detection of increasing MC and relapse may permit timely implementation of therapeutic measures.